301 related articles for article (PubMed ID: 18536523)
1. The promise and perils of 'targeted therapy' of advanced ovarian cancer.
Markman M
Oncology; 2008; 74(1-2):1-6. PubMed ID: 18536523
[TBL] [Abstract][Full Text] [Related]
2. The future of targeted therapies in ovarian cancer.
Banerjee S; Gore M
Oncologist; 2009 Jul; 14(7):706-16. PubMed ID: 19592450
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.
Newton HB
Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572
[TBL] [Abstract][Full Text] [Related]
4. Targeted trials in ovarian cancer.
Ledermann JA; Raja FA
Gynecol Oncol; 2010 Oct; 119(1):151-6. PubMed ID: 20591473
[TBL] [Abstract][Full Text] [Related]
5. From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents.
Morin MJ
Oncogene; 2000 Dec; 19(56):6574-83. PubMed ID: 11426642
[TBL] [Abstract][Full Text] [Related]
6. [New drugs and targeted therapeutic agents in ovarian cancer].
de La Motte Rouge T; Petrella MC; Michels J; Even C; Balleyguier C; Duclos J; Mazeron R; Morice P; Pautier P; Lhommé C
Bull Cancer; 2009 Dec; 96(12):1215-24. PubMed ID: 19919916
[TBL] [Abstract][Full Text] [Related]
7. Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.
Tortora G; Ciardiello F; Gasparini G
Nat Clin Pract Oncol; 2008 Sep; 5(9):521-30. PubMed ID: 18594498
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody therapy of ovarian cancer.
Nicodemus CF; Berek JS
Expert Rev Anticancer Ther; 2005 Feb; 5(1):87-96. PubMed ID: 15757441
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of anti-angiogenic therapy in ovarian cancer (review).
Conteduca V; Kopf B; Burgio SL; Bianchi E; Amadori D; De Giorgi U
Int J Oncol; 2014 May; 44(5):1417-24. PubMed ID: 24626312
[TBL] [Abstract][Full Text] [Related]
10. Targeting growth factors and angiogenesis; using small molecules in malignancy.
Wanebo HJ; Argiris A; Bergsland E; Agarwala S; Rugo H
Cancer Metastasis Rev; 2006 Jun; 25(2):279-92. PubMed ID: 16770540
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapies: a nursing perspective.
Kay P
Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
[TBL] [Abstract][Full Text] [Related]
12. New therapies for ovarian cancer: cytotoxics and molecularly targeted agents.
Dinh P; Harnett P; Piccart-Gebhart MJ; Awada A
Crit Rev Oncol Hematol; 2008 Aug; 67(2):103-12. PubMed ID: 18342536
[TBL] [Abstract][Full Text] [Related]
13. Promising molecular targets in ovarian cancer.
Blagden S; Gabra H
Curr Opin Oncol; 2009 Sep; 21(5):412-9. PubMed ID: 19553815
[TBL] [Abstract][Full Text] [Related]
14. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
Wagner AD; Moehler M
Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
[TBL] [Abstract][Full Text] [Related]
15. Thyroid cancer molecular signaling pathways and use of targeted therapy.
Kundra P; Burman KD
Endocrinol Metab Clin North Am; 2007 Sep; 36(3):839-53, viii. PubMed ID: 17673131
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategies.
Markman M
Trends Pharmacol Sci; 2008 Oct; 29(10):515-9. PubMed ID: 18760845
[TBL] [Abstract][Full Text] [Related]
17. Combining molecular therapeutics with radiotherapy for head and neck cancer.
Riesterer O; Milas L; Ang KK
J Surg Oncol; 2008 Jun; 97(8):708-11. PubMed ID: 18493923
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategies for triple-negative breast cancer.
Tan AR; Swain SM
Cancer J; 2008; 14(6):343-51. PubMed ID: 19060597
[TBL] [Abstract][Full Text] [Related]
19. The role of targeted therapy in ovarian cancer.
Banerjee S; Kaye S
Eur J Cancer; 2011 Sep; 47 Suppl 3():S116-30. PubMed ID: 21943965
[TBL] [Abstract][Full Text] [Related]
20. New anticancer agents and therapeutic strategies in development for solid cancers: a clinical perspective.
Awada A; Mano M; Hendlisz A; Piccart M
Expert Rev Anticancer Ther; 2004 Feb; 4(1):53-60. PubMed ID: 14748657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]